Clinical Trial Manager
I am a Clinical Trials Manager responsible for the World Hip Trauma Evaluation (WHiTE) Cohort Study and the embedded randomised controlled trials, WHiTE 8 - Copal and FRUITI.
The WHiTE research projects are focused on the management of femoral fractures in older patients. The cohort study is an observational study which has been running since 2014 and moved its sponsorship from Warwick to Oxford in September 2016. This study collects routine data and patient-reported outcomes of all recruited hip fracture patients over the age of 60 in over 40 NHS secondary care centres in England. WHiTE 8 - Copal is one of the RCTs embedded into the cohort study and aims to see whether a high does, dual-antibiotic loaded bone cement makes a difference is reducing deep surgical site infection in patients receiving a hip hemiarthroplasty after fracture, compared to a single dose antibiotic loaded cement. FRUITI is an NIHR HTA funded trial looking into fixation vs hip replacement in minimally displaced intracapsular hip fractures in the same patient group.
My work involves writing and maintaining up-to-date study documentation and liaising with relevant key staff, collaborators and researchers to ensure that all aspects of the research comply with Good Clinical Practice (GCP) and standard operating procedures.
Prior to joining the Critical Care, Trauma, and Rehabilitation (CCTR) Trials Group, I worked as an acting Trial Coordinator for the MiniDex trial and an Administrative Assistant with the PITCHES trial, both at the National Perinatal Epidemiology Unit (NPEU) at the University of Oxford. I am Canadian, and my background is in education and administration. I moved to the UK in June 2015 from Thailand, where I lived for 13 years.